What will happen to Elite's share price when generic Percocet and generic Norco are approved and ANDA for generic ADF Oxycitin is submitted to the FDA?
Elite is a real company trying to make things happen. Don't forget that they have FDA approved drugs being manufactured and sold now.
The good news is SequestOx is not dead, and we are currently reformulating and testing the various potential formulations in vitro until we shorten this Tmax value with two more consultants on board!
I have no concern that this can be done. Just remember that these are drugs in their generic life cycle. Safe and effective when use as intended...no major adverse event or deaths in clinical trials.
It is not like we have a drug molecule that causes liver damage, kidney failure, adverse cardiovascular event, adverse psychotropic event, or not efficacious at all.
Therefore, we can keep on reformulating until we get it right.
We just have to find the right formulation with a faster Tmax.
Our sound Abuse Deterrent Technology is so needed right now to help curb this opiod epidemic/crisis.
I believe that Nasrat will eventually be able to solve this Tmax issue with his current team and with the two additional consultants.
I am sure that he is also still looking for more consultants/formulators if these new two are not able to help crack the Tmax code.
In the meantime, these upcoming revenue producing events listed below will significant improve our bottom line.
Catalysts for significant revenue growth and improvement of share price in the very near future!
2. Oxycodone Hydrochloride ER with ADT 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg Tablets (Generic OxyContin ADT) Pending ANDA submittal Submittal this quarter Positive, top line BE results press released on 1/17/17
News 
Market Data 
Discover 
